Viewing Study NCT00697866


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-02-20 @ 6:38 PM
Study NCT ID: NCT00697866
Status: COMPLETED
Last Update Posted: 2016-09-16
First Post: 2008-06-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module